News & Events Upcoming events Oct 21, 2026 - Oct 23, 2026 MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Meeting Toronto, Canada More info and meet us there Nov 16, 2026 - Nov 19, 2026 MEDICA 2026 Düsseldorf, Germany More info and meet us there Nov 16, 2026 - Nov 19, 2026 19th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA, United States of America More info and meet us there See all upcoming events Latest news Jan 26, 2009 Fujirebio Diagnostics and Abbott Agree to Develop New Ovarian Cancer Test for Abbott's ARCHITECT® Analyzers Read more Jan 25, 2009 Pivotal Data Published for First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass Read more Dec 15, 2008 Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test Read more Oct 5, 2008 Fujirebio Diagnostics Named One of the Best Places to Work Read more Jun 18, 2008 Fujirebio Diagnostics Receives FDA Clearance for the HE4 EIA Assay for the monitoring of patients with ovarian cancer Read more Apr 1, 2008 Fujirebio Diagnostics Acquires American Biological Technologies Read more Load More
Oct 21, 2026 - Oct 23, 2026 MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Meeting Toronto, Canada More info and meet us there
Nov 16, 2026 - Nov 19, 2026 19th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA, United States of America More info and meet us there
Jan 26, 2009 Fujirebio Diagnostics and Abbott Agree to Develop New Ovarian Cancer Test for Abbott's ARCHITECT® Analyzers Read more
Jan 25, 2009 Pivotal Data Published for First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass Read more
Dec 15, 2008 Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test Read more
Jun 18, 2008 Fujirebio Diagnostics Receives FDA Clearance for the HE4 EIA Assay for the monitoring of patients with ovarian cancer Read more
